Literature DB >> 25982839

Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories.

Hyun Seok Hwang1, Dmytro O Kryshtal1, T K Feaster2, Verónica Sánchez-Freire3, Jianhua Zhang4, Timothy J Kamp4, Charles C Hong5, Joseph C Wu3, Björn C Knollmann6.   

Abstract

Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are being increasingly used to model human heart diseases. hiPSC-CMs generated by earlier aggregation-based methods (i.e., embryoid body) often lack functional sarcoplasmic reticulum (SR) Ca stores characteristic of mature mammalian CMs. Newer monolayer-based cardiac differentiation methods (i.e., Matrigel sandwich or small molecule-based differentiation) produce hiPSC-CMs of high purity and yield, but their Ca handling has not been comprehensively investigated. Here, we studied Ca handling and cytosolic Ca buffering properties of hiPSC-CMs generated independently from multiple hiPSC lines at Stanford University, Vanderbilt University and University of Wisconsin-Madison. hiPSC-CMs were cryopreserved at each university. Frozen aliquots were shipped, recovered from cryopreservation, plated at low density and compared 3-5days after plating with acutely-isolated adult rabbit and mouse ventricular CMs. Although hiPSC-CM cell volume was significantly smaller, cell capacitance to cell volume ratio and cytoplasmic Ca buffering were not different from rabbit-CMs. hiPSC-CMs from all three laboratories exhibited robust L-type Ca currents, twitch Ca transients and caffeine-releasable SR Ca stores comparable to adult CMs. Ca transport by sarcoendoplasmic reticulum Ca ATPase (SERCA) and Na/Ca exchanger (NCX) was similar in all hiPSC-CM lines, but slower compared to rabbit-CMs. However, the relative contribution of SERCA and NCX to Ca transport of hiPSC-CMs was comparable to rabbit-CMs. Ca handling maturity of hiPSC-CMs increased from 15 to 21days post-induction. We conclude that hiPSC-CMs generated independently from multiple iPSC lines using monolayer-based methods can be reproducibly recovered from cryopreservation and exhibit comparable and functional SR Ca handling.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25982839      PMCID: PMC4530041          DOI: 10.1016/j.yjmcc.2015.05.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  42 in total

1.  Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.

Authors:  Tilmann Schober; Sabine Huke; Raghav Venkataraman; Oleksiy Gryshchenko; Dmytro Kryshtal; Hyun Seok Hwang; Franz J Baudenbacher; Björn C Knollmann
Journal:  Circ Res       Date:  2012-05-29       Impact factor: 17.367

2.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

Review 3.  Calcium signaling in cardiac myocytes.

Authors:  Claire J Fearnley; H Llewelyn Roderick; Martin D Bootman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

4.  Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Yee-Ki Lee; Kwong-Man Ng; Wing-Hon Lai; Yau-Chi Chan; Yee-Man Lau; Qizhou Lian; Hung-Fat Tse; Chung-Wah Siu
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

5.  Models of excitation-contraction coupling in cardiac ventricular myocytes.

Authors:  M Saleet Jafri
Journal:  Methods Mol Biol       Date:  2012

6.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

7.  Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.

Authors:  Jianhua Zhang; Matthew Klos; Gisela F Wilson; Amanda M Herman; Xiaojun Lian; Kunil K Raval; Matthew R Barron; Luqia Hou; Andrew G Soerens; Junying Yu; Sean P Palecek; Gary E Lyons; James A Thomson; Todd J Herron; José Jalife; Timothy J Kamp
Journal:  Circ Res       Date:  2012-08-21       Impact factor: 17.367

8.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

Review 9.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

10.  Calcium handling in human induced pluripotent stem cell derived cardiomyocytes.

Authors:  Ilanit Itzhaki; Sophia Rapoport; Irit Huber; Itzhak Mizrahi; Limor Zwi-Dantsis; Gil Arbel; Jackie Schiller; Lior Gepstein
Journal:  PLoS One       Date:  2011-04-01       Impact factor: 3.240

View more
  70 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

2.  Rigorous Phenotyping of Cardiac iPSC Preparations Requires Knowledge of Their Resting Potential(s).

Authors:  Wayne R Giles; Denis Noble
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

3.  Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy.

Authors:  Adam S Helms; Vi T Tang; Thomas S O'Leary; Sabrina Friedline; Mick Wauchope; Akul Arora; Aaron H Wasserman; Eric D Smith; Lap Man Lee; Xiaoquan W Wen; Jordan A Shavit; Allen P Liu; Michael J Previs; Sharlene M Day
Journal:  JCI Insight       Date:  2020-01-30

4.  A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.

Authors:  Worawan B Limpitikul; Ivy E Dick; David J Tester; Nicole J Boczek; Pattraranee Limphong; Wanjun Yang; Myoung Hyun Choi; Jennifer Babich; Deborah DiSilvestre; Ronald J Kanter; Gordon F Tomaselli; Michael J Ackerman; David T Yue
Journal:  Circ Res       Date:  2016-10-20       Impact factor: 17.367

Review 5.  The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Authors:  Lingqun Ye; Xuan Ni; Zhen-Ao Zhao; Wei Lei; Shijun Hu
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

6.  Myofilament Calcium-Buffering Dependent Action Potential Triangulation in Human-Induced Pluripotent Stem Cell Model of Hypertrophic Cardiomyopathy.

Authors:  Lili Wang; Dmytro O Kryshtal; Kyungsoo Kim; Shan Parikh; Adrian Gabriel Cadar; Kevin Richard Bersell; Huan He; Jose R Pinto; Bjorn C Knollmann
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

7.  Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.

Authors:  Lili Wang; Kyungsoo Kim; Shan Parikh; Adrian Gabriel Cadar; Kevin R Bersell; Huan He; Jose R Pinto; Dmytro O Kryshtal; Bjorn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2017-12-05       Impact factor: 5.000

Review 8.  Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Authors:  Shi Hua Tan; Lei Ye
Journal:  J Cardiovasc Transl Res       Date:  2018-03-19       Impact factor: 4.132

Review 9.  Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.

Authors:  Fikru B Bedada; Matthew Wheelwright; Joseph M Metzger
Journal:  Biochim Biophys Acta       Date:  2015-11-11

10.  Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.

Authors:  Guihua Jiang; Todd J Herron; Julie Di Bernardo; Kendal A Walker; K Sue O'Shea; Shaun M Kunisaki
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.